Page |1
WGU D116 ADVANCED PHARMACOLOGY –
COMPREHENSIVE ASSESSMENT | STUDY
GUIDE | LATEST UPDATE 2026/2027 |
PRACTICE QUESTIONS AND ANSWERS |
EXAM REVIEW
TABLE OF CONTENTS
1. Foundational Principles of Pharmacokinetics and Pharmacodynamics
2. Drug Development, Regulation, and Ethical Considerations
3. Autonomic Nervous System Pharmacology
4. Cardiovascular and Renal Pharmacology
5. Respiratory and Allergy Pharmacology
6. Endocrine and Metabolic Pharmacology
7. Neurologic and Psychiatric Pharmacology
8. Infectious Disease and Antimicrobial Pharmacology
9. Special Populations and Toxicologic Considerations
10. Clinical Application and Evidence-Based Prescribing
, Page |2
Question 1: Which of the following best describes pharmacokinetics?
A) The study of drug effects on the body and mechanism of action
B) The study of drug absorption, distribution, metabolism, and excretion
C) The study of drug toxicity and adverse effects
D) The study of drug-receptor interactions
Correct Answer: B) The study of drug absorption, distribution, metabolism, and
excretion
Pharmacokinetics is what the body does to a drug and encompasses the four primary
processes: absorption, distribution, metabolism, and excretion (ADME). Pharmacodynamics,
by contrast, is what the drug does to the body. Understanding ADME is essential for
determining appropriate dosing regimens and predicting drug behavior in patients.
Question 2: A nurse practitioner is assessing a client with hepatic impairment who is
prescribed a medication metabolized by CYP3A4. Which pharmacokinetic process is most
affected?
A) Absorption
B) Distribution
C) Metabolism
D) Excretion
Correct Answer: C) Metabolism
Hepatic impairment primarily alters drug metabolism through Phase I reactions involving
cytochrome P450 enzymes such as CYP3A4. This can lead to prolonged drug half-life, drug
accumulation, and increased toxicity risk. Dose adjustments are often necessary for
hepatically metabolized medications.
Question 3: The first-pass effect refers to:
A) Rapid intravenous administration of a drug
B) Drug metabolism in the liver before reaching systemic circulation
, Page |3
C) Drug excretion by the kidneys
D) Drug binding to plasma proteins
Correct Answer: B) Drug metabolism in the liver before reaching systemic circulation
The first-pass effect occurs when orally administered drugs are metabolized in the liver
before entering systemic circulation, significantly reducing bioavailability. Drugs with high
first-pass metabolism, such as nitroglycerin and morphine, require higher oral doses or
alternative routes of administration.
Question 4: Which route of administration completely bypasses the first-pass effect?
A) Oral
B) Rectal
C) Sublingual
D) Enteric-coated oral
Correct Answer: C) Sublingual
Sublingual administration allows direct absorption into systemic circulation through the
venous drainage of the oral mucosa, completely bypassing hepatic first-pass metabolism.
This route provides rapid onset of action and is particularly useful for medications like
nitroglycerin.
Question 5: Bioavailability is defined as:
A) The speed of drug absorption
B) The fraction of an administered dose that reaches systemic circulation unchanged
C) The volume of distribution
D) The half-life of the drug
Correct Answer: B) The fraction of an administered dose that reaches systemic
circulation unchanged
Bioavailability represents the proportion of a drug that enters systemic circulation in an
active form. Intravenous administration provides 100% bioavailability, while oral
bioavailability is reduced by incomplete absorption and first-pass metabolism.
, Page |4
Question 6: Which route of administration has the highest bioavailability?
A) Oral
B) Subcutaneous
C) Intravenous
D) Intramuscular
Correct Answer: C) Intravenous
Intravenous administration bypasses absorption barriers and first-pass metabolism,
delivering 100% of the dose directly into systemic circulation. This route provides the most
predictable and immediate drug effect. Other parenteral routes have variable absorption
rates.
Question 7: A drug with a narrow therapeutic index requires:
A) Less frequent monitoring
B) Close monitoring of serum drug levels
C) No special precautions
D) Higher doses for efficacy
Correct Answer: B) Close monitoring of serum drug levels
Narrow therapeutic index drugs have a small margin between therapeutic and toxic doses.
Serum level monitoring is essential to maintain concentrations within the therapeutic range
and prevent toxicity. Examples include digoxin, lithium, and warfarin.
Question 8: In pharmacodynamics, a drug that binds to a receptor and activates it to produce
a full biological response is classified as:
A) Antagonist
B) Partial agonist
C) Inverse agonist
D) Full agonist
Correct Answer: D) Full agonist
WGU D116 ADVANCED PHARMACOLOGY –
COMPREHENSIVE ASSESSMENT | STUDY
GUIDE | LATEST UPDATE 2026/2027 |
PRACTICE QUESTIONS AND ANSWERS |
EXAM REVIEW
TABLE OF CONTENTS
1. Foundational Principles of Pharmacokinetics and Pharmacodynamics
2. Drug Development, Regulation, and Ethical Considerations
3. Autonomic Nervous System Pharmacology
4. Cardiovascular and Renal Pharmacology
5. Respiratory and Allergy Pharmacology
6. Endocrine and Metabolic Pharmacology
7. Neurologic and Psychiatric Pharmacology
8. Infectious Disease and Antimicrobial Pharmacology
9. Special Populations and Toxicologic Considerations
10. Clinical Application and Evidence-Based Prescribing
, Page |2
Question 1: Which of the following best describes pharmacokinetics?
A) The study of drug effects on the body and mechanism of action
B) The study of drug absorption, distribution, metabolism, and excretion
C) The study of drug toxicity and adverse effects
D) The study of drug-receptor interactions
Correct Answer: B) The study of drug absorption, distribution, metabolism, and
excretion
Pharmacokinetics is what the body does to a drug and encompasses the four primary
processes: absorption, distribution, metabolism, and excretion (ADME). Pharmacodynamics,
by contrast, is what the drug does to the body. Understanding ADME is essential for
determining appropriate dosing regimens and predicting drug behavior in patients.
Question 2: A nurse practitioner is assessing a client with hepatic impairment who is
prescribed a medication metabolized by CYP3A4. Which pharmacokinetic process is most
affected?
A) Absorption
B) Distribution
C) Metabolism
D) Excretion
Correct Answer: C) Metabolism
Hepatic impairment primarily alters drug metabolism through Phase I reactions involving
cytochrome P450 enzymes such as CYP3A4. This can lead to prolonged drug half-life, drug
accumulation, and increased toxicity risk. Dose adjustments are often necessary for
hepatically metabolized medications.
Question 3: The first-pass effect refers to:
A) Rapid intravenous administration of a drug
B) Drug metabolism in the liver before reaching systemic circulation
, Page |3
C) Drug excretion by the kidneys
D) Drug binding to plasma proteins
Correct Answer: B) Drug metabolism in the liver before reaching systemic circulation
The first-pass effect occurs when orally administered drugs are metabolized in the liver
before entering systemic circulation, significantly reducing bioavailability. Drugs with high
first-pass metabolism, such as nitroglycerin and morphine, require higher oral doses or
alternative routes of administration.
Question 4: Which route of administration completely bypasses the first-pass effect?
A) Oral
B) Rectal
C) Sublingual
D) Enteric-coated oral
Correct Answer: C) Sublingual
Sublingual administration allows direct absorption into systemic circulation through the
venous drainage of the oral mucosa, completely bypassing hepatic first-pass metabolism.
This route provides rapid onset of action and is particularly useful for medications like
nitroglycerin.
Question 5: Bioavailability is defined as:
A) The speed of drug absorption
B) The fraction of an administered dose that reaches systemic circulation unchanged
C) The volume of distribution
D) The half-life of the drug
Correct Answer: B) The fraction of an administered dose that reaches systemic
circulation unchanged
Bioavailability represents the proportion of a drug that enters systemic circulation in an
active form. Intravenous administration provides 100% bioavailability, while oral
bioavailability is reduced by incomplete absorption and first-pass metabolism.
, Page |4
Question 6: Which route of administration has the highest bioavailability?
A) Oral
B) Subcutaneous
C) Intravenous
D) Intramuscular
Correct Answer: C) Intravenous
Intravenous administration bypasses absorption barriers and first-pass metabolism,
delivering 100% of the dose directly into systemic circulation. This route provides the most
predictable and immediate drug effect. Other parenteral routes have variable absorption
rates.
Question 7: A drug with a narrow therapeutic index requires:
A) Less frequent monitoring
B) Close monitoring of serum drug levels
C) No special precautions
D) Higher doses for efficacy
Correct Answer: B) Close monitoring of serum drug levels
Narrow therapeutic index drugs have a small margin between therapeutic and toxic doses.
Serum level monitoring is essential to maintain concentrations within the therapeutic range
and prevent toxicity. Examples include digoxin, lithium, and warfarin.
Question 8: In pharmacodynamics, a drug that binds to a receptor and activates it to produce
a full biological response is classified as:
A) Antagonist
B) Partial agonist
C) Inverse agonist
D) Full agonist
Correct Answer: D) Full agonist
